The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
26 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,069,791 in first-year total cost, median $40,649.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-R (A1)]26
Most frequent institutions
- DUKE UNIVERSITY1
- EMORY UNIVERSITY1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- HARVARD UNIVERSITY1
- MICHIGAN STATE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Tumor Intrinsic Regulation of Immune Evasion Pathways in Melanoma1F99CA245552-01 | ROSENBAUM, SHEERA | THOMAS JEFFERSON UNIVERSITY, PA | $46,516 | ZCA1 |
| 2019 | Targeting the Nrf2 pathway in cancer1F99CA245473-01 | ZHANG, DI | MICHIGAN STATE UNIVERSITY, MI | $46,516 | ZCA1 |
| 2019 | Role of novel cis-acting long non-coding RNAs in DNA replication timing and chromosome stability in cancer1F99CA245677-01 | HESKETT, MICHAEL B | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $46,516 | ZCA1 |
| 2019 | Genome Integrity Through the Cell Cycle in Homeostasis and Cancer1F99CA245720-01 | MIRMAN, ZACHARY KENNETH | ROCKEFELLER UNIVERSITY, NY | $46,516 | ZCA1 |
| 2019 | Identifying Metabolic Vulnerabilities in Pancreatic Cancer1F99CA245822-01 | BIANCUR, DOUGLAS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $46,516 | ZCA1 |
| 2019 | Identifying mechanisms of response and resistance to immunotherapies in lung cancer1F99CA245819-01 | ROBLES-OTEIZA, CAMILA | YALE UNIVERSITY, CT | $46,516 | ZCA1 |
| 2019 | Dissecting the mechanisms of immune surveillance and evasion in liver cancer1F99CA245797-01 | CHEN, HSUAN-AN | SLOAN-KETTERING INST CAN RESEARCH, NY | $46,516 | ZCA1 |
| 2019 | The mechanical role of the glycocalyx in cancer cell adhesion1F99CA245789-01 | BLANCHARD, AARON | EMORY UNIVERSITY, GA | $46,516 | ZCA1 |
| 2019 | Biological and cancer-associated role of epitranscriptomic gene expression regulation1F99CA245784-01 | DOLCEN, DENIZ NESLI | UNIVERSITY OF CHICAGO, IL | $46,516 | ZCA1 |
| 2019 | DNA methylation regulation through the UHRF1 oncoprotein1F99CA245821-01 | VAUGHAN, ROBERT MARK | VAN ANDEL INSTITUTE GRADUATE SCHOOL, MI | $45,516 | ZCA1 |
| 2019 | Expanding the scope of protein degradation and stability using chemoproteomic platforms1F99CA245718-01 | WARD, CARL | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $42,172 | ZCA1 |
| 2019 | Dissecting the molecular mechanism of heterochromatin misregulation at the nuclear periphery in cancer1F99CA245719-01 | KEENEN, MADELINE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $41,561 | ZCA1 |
| 2019 | Profiling and leveraging bystander T cells within the tumor microenvironment1F99CA245735-01 | MAURICE, NICHOLAS JOSEPH | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $40,702 | ZCA1 |
| 2019 | The regulation of innate immune sensors to control GVHD and GVL after allogeneic hematopoietic stem cell transplantation1F99CA245728-01 | BADER, CAMERON SCOTT | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $40,596 | ZCA1 |
| 2019 | A multi-level mixed methods examination of treatment non-adherence among rural oncology patients1F99CA245799-01 | MORRIS, BONNY | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $40,229 | ZCA1 |
| 2019 | Mechanisms of Cell Cycle and Cell Identity Regulation that Influence Sensitivity to Targeted Therapies1F99CA245471-01 | CHAIKOVSKY, ANDREA CHRISTINE | STANFORD UNIVERSITY, CA | $39,312 | ZCA1 |
| 2019 | Protein Phosphatase PP2A and DNA damage in cell fate decisions of acute myeloid leukemic cells1F99CA245813-01 | GOSWAMI, SWAGATA | OHIO STATE UNIVERSITY, OH | $39,015 | ZCA1 |
| 2019 | Exploring mechanisms of transcriptional and chromatin dysregulation in cancer1F99CA245825-01 | PAROLIA, ABHIJIT | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $38,516 | ZCA1 |
| 2019 | Uncovering actionable signaling pathways required for solid tumor brain metastasis1F99CA245732-01 | HOJ, JACOB PETER | DUKE UNIVERSITY, NC | $38,157 | ZCA1 |
| 2019 | Deciphering the Role of Gut Microbiome in Colitis-Associated Colorectal Cancer Using a Patient-Specific Disease-on-a-Chip1F99CA245801-01 | SHIN, WOOJUNG | UNIVERSITY OF TEXAS AT AUSTIN, TX | $38,036 | ZCA1 |
| 2019 | Nuclear Receptor Regulation of Epigenetics in Endocrine-Related Cancers1F99CA245796-01 | GILLIS, NOELLE ELIZABETH | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $37,325 | ZCA1 |
| 2019 | Determining the role of dendritic cells and spatial localization in anti-tumor immunity1F99CA245807-01 | GARDNER, ALYCIA | UNIVERSITY OF SOUTH FLORIDA, FL | $35,526 | ZCA1 |
| 2019 | Ceramide NanoLiposomes as a novel therapeutic for prostate cancer1F99CA245802-01 | DA COSTA PINHEIRO, PEDRO FILIPE | UNIVERSITY OF VIRGINIA, VA | $34,961 | ZCA1 |
| 2019 | Mechanistic studies and therapeutic targeting of the WNT signaling pathway1F99CA245724-01 | AGAJANIAN, MEGAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $34,324 | ZCA1 |
| 2019 | Selective targeting of tumor cell redox metabolism and DNA damage responses to enhance cancer therapy1F99CA245722-01 | HEER, COLLIN DAVID | UNIVERSITY OF IOWA, IA | $32,776 | ZCA1 |
| 2019 | Statistical framework for assessing drug sensitivity in vitro and linking patient outcomes1F99CA245736-01 | PLOENZKE, MATTHEW | HARVARD UNIVERSITY, MA | $32,423 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.